High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection.
about
Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infectionRole of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directionsTherapy of Helicobacter pylori: present medley and future prospectiveSystematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infectionCurrent Helicobacter pylori treatment in 2014Meta-analysis: is combination of tetracycline and amoxicillin suitable for Helicobacter pylori infection?'Rescue' therapies for the management of Helicobacter pylori infection.Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale.Real-time PCR screening for 16S rRNA mutations associated with resistance to tetracycline in Helicobacter pylori.Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensusSecond-line rescue therapy of helicobacter pylori infection.A new look at anti-Helicobacter pylori therapyA randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pyloriLow efficacy of levofloxacin-doxycycline-based third-line triple therapy for Helicobacter pylori eradication in Italy.Dual therapy trial using esomeprazole and amoxicillin as third-line rescue therapy for Helicobacter pylori infection.Helicobacter pylori "rescue" therapy after failure of two eradication treatments.Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.Effective regimens for the treatment of Helicobacter pylori infection.Helicobacter pylori eradication therapy: A review of current trends.A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication"Rescue" regimens after Helicobacter pylori treatment failure.Helicobacter pylori eradication therapy.Culture-guided treatment approach for Helicobacter pylori infection: review of the literature.Attempts to enhance the eradication rate of Helicobacter pylori infectionHelicobacter pylori: management in 2013.Fluoroquinolone-based protocols for eradication of Helicobacter pyloriQuinolone-containing therapies in the eradication of Helicobacter pyloriEmerging therapies for the treatment of Helicobacter pylori infections.Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial.How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.Antimicrobial susceptibility and clarithromycin resistance patterns of Helicobacter pylori clinical isolates in Vietnam.H. pylori Management in ASEAN: the Bangkok Consensus Report.Comparison of the efficacy of culture-based tailored therapy for Helicobacter pylori eradication with that of the traditional second-line rescue therapy in Korean patients: a prospective single tertiary center study.Eradication of H. pylori Infection: the Challenge is on if Standard Therapy FailsA Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study.Update on triple therapy for eradication of Helicobacter pylori: current status of the artThe Optimal First-Line Therapy of Helicobacter pylori Infection in Year 2012.Third-line rescue therapy for Helicobacter pylori infection.A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.
P2860
Q26745727-4B60F8ED-BB48-4BB7-80E2-3C1A6DC59F52Q26778023-D62DEF35-83ED-4670-B48B-0D2839293F1FQ26823120-422AA621-FEF5-4ABD-A7CF-AF10BD17FF6CQ26853010-0F5EC1AB-2FC9-4163-96EC-F1B6DCD4F35DQ27000209-08F72FD1-9844-4317-B6CA-B5182E1225E5Q28082104-B3D6BC52-A6CD-48ED-A95A-C154826DA241Q33371187-0F425B17-6B9F-452D-A770-DCA9FD8592E5Q33698340-9D1D3E23-3049-4969-987A-20DD9680EFFDQ33938262-88408888-599A-4C27-90FD-B7A567B51A01Q34067951-0BEA52BD-F7C1-42B5-B024-182908D3DC19Q34409114-9AF3BD94-2240-4E55-BA1C-54FFC98C05EEQ35424549-A1A69CB6-E86C-4C98-A3D2-905E1C1A5B73Q35532235-4FCB3B95-F4D0-4300-B472-FD053B3DFAAFQ35692337-5C1C2DB7-6B38-4ACF-AE45-4C5741B26DA1Q35997133-8BE58C29-5275-4EED-A128-B99073BF4A42Q36266517-13044DE6-16C2-4651-A21B-EA4CA9C19EEEQ36360546-09C4B18D-9D03-4BF4-91FD-C3F4E005B68CQ36423165-88A6FF78-0B5F-48A7-B60E-734BD27AA912Q36568724-7C158519-5A3E-47D3-9D6C-0EFC1239B68DQ36817663-3CA30A43-0F11-43DE-9336-D6B3DC93A156Q36993414-C277D0B4-A394-432D-84D6-210328CC99CCQ37273653-FF1A9D4A-6B5B-412F-8087-9B3D63377E9DQ37721423-14C29C3D-AA8E-410B-AB02-16F3AC6C937FQ38212210-B9769E9B-0449-4206-A631-0836699D258FQ38212213-EABB2050-29D5-4C28-A5EC-E03EABFB6A08Q38212214-9E64F3FB-085C-4E20-9611-BC928F8AB56DQ38235943-17A39BE3-E9D0-4C61-9B12-2B9FD437BDDFQ38253054-4544F524-A017-402B-99E6-35F055086886Q38424698-1A52432B-4074-4B7D-9B8E-D28B0B8B74F3Q38462098-68E416EE-B61B-416F-92D4-BE9ACD992E86Q38575216-1359468E-A9AD-498A-911D-1706ACBAE9A0Q38825524-7E934E83-21FC-473A-9587-82A691EC314EQ40100019-14B26E74-69DA-4672-8BAB-95CD1338E94BQ40959633-A15C9A67-57FA-4632-9BBF-8F3D3B88C4F3Q41172569-1573E857-CC42-4E28-8803-047F9F46255CQ41391795-9D6129F8-5762-44DD-81C8-FCC416D0F68BQ42094393-459F7EDA-E4FF-43CB-80F6-9F3622C5E91EQ42121382-38DDAACC-09A9-4FCC-BDCB-0374D1EBD5D3Q42726333-38CE2F12-6F36-4FC9-ABD3-8249DC63DCD5Q46552854-76CF75CF-766B-43B4-8382-C00BBB947B8F
P2860
High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
High efficacy of 1-week doxycy ...... Helicobacter pylori infection.
@en
High efficacy of 1-week doxycy ...... Helicobacter pylori infection.
@nl
type
label
High efficacy of 1-week doxycy ...... Helicobacter pylori infection.
@en
High efficacy of 1-week doxycy ...... Helicobacter pylori infection.
@nl
prefLabel
High efficacy of 1-week doxycy ...... Helicobacter pylori infection.
@en
High efficacy of 1-week doxycy ...... Helicobacter pylori infection.
@nl
P2093
P2860
P1476
High efficacy of 1-week doxycy ...... Helicobacter pylori infection.
@en
P2093
Cammarota G
Cannizzaro O
Gasbarrini A
Gasbarrini G
P2860
P304
P356
10.1111/J.1365-2036.2004.01910.X
P407
P577
2004-04-01T00:00:00Z